Intensivmedizin und Notfallmedizin

, Volume 48, Issue 3, pp 199–206 | Cite as

Therapie der posttraumatischen abdominellen Sepsis

  • A. Sablotzki
  • M. Fuchs
  • J. Gille
  • A. Weimann
  • E. Czeslick
Übersicht
  • 130 Downloads

Zusammenfassung

Die posttraumatische Peritonitis ist die häufigste und schwerste Komplikation nach einem abdominellen Trauma. Das so induzierte septische Multiorganversagen bedingt eine langwierige intensivmedizinische Behandlung, ist schwer zu therapieren und mit einer hohen Letalität behaftet. In der nachfolgenden Übersicht werden die ätiologischen Faktoren und die möglichen therapeutischen Konzepte vorgestellt und diskutiert, die dazu beitragen können, die immer noch unbefriedigenden Behandlungsergebnisse zu verbessern.

Schlüsselwörter

Sepsis Posttraumatische Peritonitis Herdsanierung Antibiotika Adjunktive Therapie 

Therapy of posttraumatic abdominal sepsis

Abstract

Posttraumatic peritonitis and abdominal sepsis are frequent and serious complications following severe abdominal injuries. When accompanied by multiorgan failure, consequences are prolonged stay in ICU, difficult treatment, and high mortality. The following review presents the pathophysiology of posttraumatic abdominal sepsis and discusses the therapeutic options which may lead to an improvement of treatment outcome.

Keywords

Sepsis Peritonitis Source elimination Antibiotics Adjunctive therapy 

Notes

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Der korrespondierende Autor erhält Honorare als Berater und/oder Referent bzw. Studienunterstützungen von Bayer Vital, CSL Behring, Edwards Lifesciences, Lilly Deutschland, Löser Medizintechnik, Serumwerk Bernburg.

Literatur

  1. 1.
    Amato MB, Barbas CS, Medeiros DM et al (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347–354PubMedCrossRefGoogle Scholar
  2. 2.
    Annane D, Sébille V, Charpentier C et al (2002) Effect of a treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMedCrossRefGoogle Scholar
  3. 3.
    Barie PS, McCollam JS, Williams MD et al (2002) Drotrecogin alfa (activated) has favorable benefit/risk profile in surgical patients with severe sepsis. Crit Care Med 30:102Google Scholar
  4. 4.
    Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709PubMedCrossRefGoogle Scholar
  5. 5.
    Braun L, Riedel A, Cooper L (2003) Hospital and follow-up costs in a severe sepsis managed care population (abstr). Crit Care Med 30:A127Google Scholar
  6. 6.
    Brunkhorst FM, Engel C, Bloos F et al (2007) Intensive insuline therapy and pentastarch resuscitation in svere sepsis. N Engl J Med 358:125–139CrossRefGoogle Scholar
  7. 7.
    Christou NV, Barie PS, Dellinger EP et al (1993) Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome. Arch Surg 128:193–199PubMedGoogle Scholar
  8. 8.
    Croce MA, Fabian TC, Stewart RM et al (1992) Correlation of Abdominal Trauma Index and Injury Severity Score with abdominal septic complications in penetrating and blunt trauma. J Trauma 32:380–388PubMedCrossRefGoogle Scholar
  9. 9.
    Davis JW, Lemaster DM, Moore EC et al (2007) Prone ventilation in trauma or surgical patients with acute lung injury and adult respiratory distress syndrome: Is it beneficial? J Trauma 62:1201–1206PubMedCrossRefGoogle Scholar
  10. 10.
    Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327PubMedCrossRefGoogle Scholar
  11. 11.
    Eggimann P, Lamoth F, Marchetti O (2009 On track to limit antifugal overuse! Intensive Care Med 35:582–584PubMedCrossRefGoogle Scholar
  12. 12.
    Gattinoni L, Tognoni G, Pesenti A for the Prone-Supine Study Group (2001) Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345:568–573PubMedCrossRefGoogle Scholar
  13. 13.
    Heyland DK, Dhaliwal R, Drover JW et al (2003) Canadian Critical Care Clinical Practice Guidelines Committee for nutrition support in mechanically ventilated critically ill adult patients. J Parenter Enteral Nutr 27:355–373CrossRefGoogle Scholar
  14. 14.
    Jhanji S, Stirling S, Patel N et al (2009) The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 37:1961–1966PubMedCrossRefGoogle Scholar
  15. 15.
    Knaebel HP, Seiler MS, Weigand MA, Büchler MW (2005) Chirurgische Therapie der Peritonitis. Intensivmedizin up2date 1:165–177CrossRefGoogle Scholar
  16. 16.
    Koretz RL, Avenell A, Lipman TO et al (2007) Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol 102:412–429PubMedCrossRefGoogle Scholar
  17. 17.
    Kreymann G, Adolph M, Druml W, Jauch KW (2007) Leitlinie Parenterale Ernährung der DGEM Intensivmedizin. Aktuel Ernaehr 32(Suppl 1):89–92CrossRefGoogle Scholar
  18. 18.
    Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRefGoogle Scholar
  19. 19.
    Lachmann B (1992) Open the lung and keep the lung open. Intensive Care Med 18:319–321PubMedCrossRefGoogle Scholar
  20. 20.
    Levi M, Cate H ten, Poll T van der (1999) Disseminated intravscular coagulation: state of the art. Thromb Haemost 82:695–705PubMedGoogle Scholar
  21. 21.
    Lipiner-Friedman D, Sprung CL, Laterre PF et al (2007) Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 35:1012–1018PubMedCrossRefGoogle Scholar
  22. 22.
    McClave SA, Martindale RG, Vanek VW et al (2009) ASPEN Board of Directors and the American College of Critical Care Medicine Guidelines fort he provision and assessment of nutrition support therapy in the adult critically patient: Society of Critical Care Med (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). J Parenter Enteral Nutr 33:277–316CrossRefGoogle Scholar
  23. 23.
    Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–3645PubMedCrossRefGoogle Scholar
  24. 24.
    Ordonez CA, Puyana JC (2006) Management of peritonitis in the critically ill patient. Surg Clin North Am 86:1323–1349PubMedCrossRefGoogle Scholar
  25. 25.
    Pappas PG, Kauffmann CA, Andes D et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503–535PubMedCrossRefGoogle Scholar
  26. 26.
    Payen D, Sablotzki A, Barie P et al (2007) International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort. Surgery 141:548–561PubMedCrossRefGoogle Scholar
  27. 27.
    Reinhart K, Brunkhorst F, Bone H et al (2006) Diagnosis and therapy of sepsis: Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine. Anaesthesist 55(Suppl 1):43–56PubMedCrossRefGoogle Scholar
  28. 28.
    Rivers E, Nguyen B, Havstad S et al (2001) Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMedCrossRefGoogle Scholar
  29. 29.
    Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877–887PubMedCrossRefGoogle Scholar
  30. 30.
    Sablotzki A, Dehne MG, Czeslick E (2008) Gestörte Homöostase in der Sepsis – Bedeutung und Therapie. AINS 43:586–593PubMedGoogle Scholar
  31. 31.
    Sablotzki A, Nestler F, Czeslick E (2005) Adjunktive Sepsistherapie – Gerinnungsinhibitoren und anti-inflammatorische Effekte. Intensivmed 42:146–155Google Scholar
  32. 32.
    Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133–164PubMedCrossRefGoogle Scholar
  33. 33.
    The Acute Respiratory Distress Syndrome Nework (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefGoogle Scholar
  34. 34.
    The NICE SUGAR Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297CrossRefGoogle Scholar
  35. 35.
    Tremblay R, Valenza F, Ribeiro SP et al (1997) Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model. J Clin Invest 282:54–61Google Scholar
  36. 36.
    Vallet B (2001) Microthrombosis in sepsis. Minerva Anesthesiol 67:298–301Google Scholar
  37. 37.
    Van den Berghe G, Wouters P, Weekers E et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367CrossRefGoogle Scholar
  38. 38.
    Van Ruler O, Mahler CW, Boer KR et al (2007) Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 298:865–872CrossRefGoogle Scholar
  39. 39.
    Vogel F, Bodmann KF et al (2004) Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Chemother J 13:46–105Google Scholar
  40. 40.
    Weimann A, With D (2003) Probleme der künstlichen Ernährung – „Trouble Shooting“. Aktuel Ernaehr Med 28:181–185CrossRefGoogle Scholar
  41. 41.
    Sablotzki A, Dehne MG, Czeslick E (2008) Gestörte Homöostase in der Sepsis. Anasthesiol Intensivmed Notfallmed Schmerzther 43(9): 586–594PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • A. Sablotzki
    • 1
  • M. Fuchs
    • 1
  • J. Gille
    • 1
  • A. Weimann
    • 2
  • E. Czeslick
    • 3
  1. 1.Klinik für Anästhesiologie, Intensiv- und SchmerztherapieKlinikum St. Georg gGmbHLeipzigDeutschland
  2. 2.Klinik für Allgemein- und ViszeralchirurgieKlinikum St. Georg LeipzigLeipzigDeutschland
  3. 3.Universitätsklinik für Anästhesiologie und Operative IntensivmedizinMartin-Luther-Universität Halle/WittenbergHalle/SaaleDeutschland

Personalised recommendations